Reassessing Twenty Years of Vaccine Development Against Tuberculosis
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a death toll of 1.7 million people in 2016 according to WHO statistics. Tuberculosis is caused by members of the Mycobacterium tuberculosis complex, facultative intracellular bacteria able to thrive wi...
Enregistré dans:
Auteur principal: | Stefan H. Kaufmann (auth) |
---|---|
Autres auteurs: | Ulrich E. Schaible (auth) |
Format: | Électronique Chapitre de livre |
Langue: | anglais |
Publié: |
Frontiers Media SA
2018
|
Collection: | Frontiers Research Topics
|
Sujets: | |
Accès en ligne: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Protective Immune Response to Dengue Virus Infection and Vaccines: perspectives from the field to the bench
par: Scott Halstead
Publié: (2015) -
Host-Directed Therapies for Tuberculosis
Publié: (2020) -
Tuberculosis in Adults and Children
par: Caws, Maxine
Publié: (2015) -
Tuberculosis in Adults and Children
par: Caws, Maxine
Publié: (2015) -
Continued Learning of Tissue-specific Immunity from the Immuno-Pathological Spectrum of Leprosy
Publié: (2020)